OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
229059

Yanbu National Petrochemical Company Yansab Sjsc

Commodity ChemicalsVerified

Yanbu National Petrochemical Company Yansab Sjsc maintains a strong liquidity position, with a current ratio of 3.7, indicating the company can cover its short-term obligations more than three times over. However, the company reported negative free cash flow of SAR -451.93 million in the latest period, driven by capital expenditures of SAR -379.03 million. Despite this, the company holds SAR 72.5 million in cash and equivalents, and its long-term debt is relatively low at SAR 102.55 million, resulting in a debt-to-equity ratio of 0.01. Profitability metrics show a return on equity (ROE) of 0.74% and a return on assets (ROA) of 0.6%, both of which are below the typical thresholds for high-performing chemical companies. The company's operating income of SAR 63.41 million and net income of SAR 79.10 million reflect modest profitability, with a gross profit of SAR 646.43 million. These figures suggest the company is operating in a low-margin segment of the chemical industry, consistent with its classification in Commodity Chemicals. The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no material geographic diversification beyond Saudi Arabia. This concentration increases exposure to regional economic and regulatory risks, particularly in the energy and chemical sectors, which are sensitive to global commodity prices and local policy shifts. Looking ahead, the company's revenue is expected to remain relatively stable, with no significant growth or contraction projected in the next fiscal year. The current fiscal year revenue of SAR 5.6 billion provides a baseline for future performance, but the absence of disclosed segment-level growth targets or geographic expansion plans suggests a conservative outlook. The company's risk profile is characterized by medium liquidity risk and low dilution risk. While the company has a strong equity base of SAR 10.75 billion, the negative free cash flow and capital expenditures indicate potential pressure on liquidity in the near term. The risk assessment also flags that net cash is negative after subtracting total debt, which could signal a need for additional financing or operational efficiency improvements. Recent filings and investor relations materials do not indicate any material events or strategic shifts in the company's operations. Analysts have assigned a mean price target of SAR 31.07, with a median of SAR 30.00, and a mean recommendation of 2.88, indicating a generally cautious outlook. The absence of strong buy ratings and the presence of five hold recommendations suggest limited upside potential in the near term.

30-day price · 2290-1.20 (-3.4%)
Low$32.02High$38.44Close$34.50As of18 May, 00:00 UTC
Profile
CompanyYanbu National Petrochemical Company Yansab Sjsc
Ticker2290.SE
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Yanbu National Petrochemical Company Yansab Sjsc is a Saudi Arabian petrochemical company that produces and markets commodity chemicals, primarily serving the plastics and industrial materials sectors.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92.

Yanbu National Petrochemical Company Yansab Sjsc maintains a strong liquidity position, with a current ratio of 3.7, indicating the company can cover its short-term obligations more than three times over. However, the company reported negative free cash flow of SAR -451.93 million in the latest period, driven by capital expenditures of SAR -379.03 million. Despite this, the company holds SAR 72.5 million in cash and equivalents, and its long-term debt is relatively low at SAR 102.55 million, resulting in a debt-to-equity ratio of 0.01. Profitability metrics show a return on equity (ROE) of 0.74% and a return on assets (ROA) of 0.6%, both of which are below the typical thresholds for high-performing chemical companies. The company's operating income of SAR 63.41 million and net income of SAR 79.10 million reflect modest profitability, with a gross profit of SAR 646.43 million. These figures suggest the company is operating in a low-margin segment of the chemical industry, consistent with its classification in Commodity Chemicals. The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no material geographic diversification beyond Saudi Arabia. This concentration increases exposure to regional economic and regulatory risks, particularly in the energy and chemical sectors, which are sensitive to global commodity prices and local policy shifts. Looking ahead, the company's revenue is expected to remain relatively stable, with no significant growth or contraction projected in the next fiscal year. The current fiscal year revenue of SAR 5.6 billion provides a baseline for future performance, but the absence of disclosed segment-level growth targets or geographic expansion plans suggests a conservative outlook. The company's risk profile is characterized by medium liquidity risk and low dilution risk. While the company has a strong equity base of SAR 10.75 billion, the negative free cash flow and capital expenditures indicate potential pressure on liquidity in the near term. The risk assessment also flags that net cash is negative after subtracting total debt, which could signal a need for additional financing or operational efficiency improvements. Recent filings and investor relations materials do not indicate any material events or strategic shifts in the company's operations. Analysts have assigned a mean price target of SAR 31.07, with a median of SAR 30.00, and a mean recommendation of 2.88, indicating a generally cautious outlook. The absence of strong buy ratings and the presence of five hold recommendations suggest limited upside potential in the near term.
Key takeaways
  • The company has a strong current ratio of 3.7, indicating solid short-term liquidity.
  • Free cash flow is negative, driven by capital expenditures, which may pressure liquidity in the near term.
  • Profitability metrics (ROE and ROA) are low, consistent with the commodity chemicals industry.
  • Revenue is concentrated in a single business segment and geographic region, increasing exposure to local economic and regulatory risks.
  • Analysts have a cautious outlook, with a mean price target of SAR 31.07 and no strong buy ratings.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencySAR
Revenue$5.60B
Gross profit$646.4M
Operating income$63.4M
Net income$79.1M
R&D
SG&A
D&A
SBC
Operating cash flow$1.22B
CapEx-$379.0M
Free cash flow-$451.9M
Total assets$13.26B
Total liabilities$2.51B
Total equity$10.75B
Cash & equivalents$72.5M
Long-term debt$102.5M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$5.60B$63.4M$79.1M-$451.9M
FY-1$6.16B$403.7M$420.3M$324.9M
FY-2$4.53B-$486.3M-$485.1M-$1.47B
FY-3$7.02B$514.8M$414.1M-$551.5M
FY-4$7.50B$1.73B$1.53B$855.5M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$13.26B$10.75B$72.5M
FY-1$14.12B$11.24B$0.00
FY-2$14.78B$11.90B$372.5M
FY-3$16.68B$14.05B$140.3M
FY-4$18.16B$15.04B$253.9M
PeriodOCFCapExFCFSBC
FY0$1.22B-$379.0M-$451.9M
FY-1$1.59B-$267.7M$324.9M
FY-2$971.6M-$918.4M-$1.47B
FY-3$1.87B-$442.6M-$551.5M
FY-4$2.64B-$403.2M$855.5M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$1.32B$12.2M$11.2M-$370.6M
FQ-1$1.38B-$58.6M-$53.3M-$18.1M
FQ-2$1.32B$66.4M$74.2M-$325.0M
FQ-3$1.39B$47.6M$44.6M$220.5M
FQ-4$1.51B$8.0M$13.7M-$329.3M
FQ-5$1.49B-$42.7M-$34.5M$156.6M
FQ-6$1.63B$138.3M$130.6M-$182.3M
FQ-7$1.66B$207.0M$224.8M$467.5M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$12.78B$10.17B$220.3M
FQ-1$13.26B$10.75B$174.6M
FQ-2$13.19B$10.79B$353.2M
FQ-3$13.66B$11.30B$301.1M
FQ-4$13.64B$11.25B$103.2M
FQ-5$14.12B$11.24B$97.7M
FQ-6$14.12B$11.78B$304.4M
FQ-7$14.54B$11.72B$665.9M
PeriodOCFCapExFCFSBC
FQ0$206.8M-$55.1M-$370.6M
FQ-1$1.22B-$379.0M-$18.1M
FQ-2$921.8M-$180.2M-$325.0M
FQ-3$485.6M-$104.2M$220.5M
FQ-4$274.1M-$46.6M-$329.3M
FQ-5$1.59B-$267.7M$156.6M
FQ-6$1.11B-$177.6M-$182.3M
FQ-7$525.4M-$128.9M$467.5M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$10.75B
Net cash-$30.0M
Current ratio3.7
Debt/Equity0.0
ROA0.6%
ROE0.7%
Cash conversion15.4%
CapEx/Revenue-6.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric2290Activity
Op margin1.1%0.4% medp25 -8.0% · p75 16.0%above median
Net margin1.4%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin11.5%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-6.8%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity1.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Mean price target31.07 SAR
Median price target30.00 SAR
High price target37.00 SAR
Low price target22.00 SAR
Mean recommendation2.88 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count2.00
Hold count5.00
Sell count1.00
Strong-sell count0.00
Mean EPS estimate0.67 SAR
Last actual EPS0.14 SAR
Source: analysis-pipeline (hybrid)Generated: 2026-05-19 00:39 UTCJob: 32ac7143